NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 213 filers reported holding NEVRO CORP in Q2 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,207,189 | -9.2% | 62,809 | +20.0% | 0.00% | 0.0% |
| Q2 2023 | $1,330,178 | -32.4% | 52,328 | -3.9% | 0.00% | 0.0% |
| Q1 2023 | $1,968,729 | -5.4% | 54,460 | +3.6% | 0.00% | 0.0% |
| Q4 2022 | $2,080,822 | +8.1% | 52,546 | +27.2% | 0.00% | 0.0% |
| Q3 2022 | $1,925,000 | -15.6% | 41,302 | -20.7% | 0.00% | 0.0% |
| Q2 2022 | $2,282,000 | -19.8% | 52,061 | +32.3% | 0.00% | 0.0% |
| Q1 2022 | $2,846,000 | -18.1% | 39,348 | -8.3% | 0.00% | -50.0% |
| Q4 2021 | $3,477,000 | -38.4% | 42,890 | -11.5% | 0.00% | -33.3% |
| Q3 2021 | $5,640,000 | -36.0% | 48,460 | -8.8% | 0.00% | -40.0% |
| Q2 2021 | $8,808,000 | +37.3% | 53,128 | +15.6% | 0.01% | +25.0% |
| Q1 2021 | $6,414,000 | +174.8% | 45,978 | +241.1% | 0.00% | +100.0% |
| Q4 2020 | $2,334,000 | +30.1% | 13,481 | +4.7% | 0.00% | 0.0% |
| Q3 2020 | $1,794,000 | +23.6% | 12,878 | +6.0% | 0.00% | +100.0% |
| Q2 2020 | $1,452,000 | +18.2% | 12,151 | -1.0% | 0.00% | 0.0% |
| Q1 2020 | $1,228,000 | -17.5% | 12,279 | -3.0% | 0.00% | -50.0% |
| Q4 2019 | $1,488,000 | +7.5% | 12,659 | -21.4% | 0.00% | 0.0% |
| Q3 2019 | $1,384,000 | +61.7% | 16,103 | +22.0% | 0.00% | +100.0% |
| Q2 2019 | $856,000 | +22.6% | 13,203 | +18.3% | 0.00% | 0.0% |
| Q1 2019 | $698,000 | +135.0% | 11,160 | +46.1% | 0.00% | – |
| Q4 2018 | $297,000 | +11.2% | 7,639 | +128.6% | 0.00% | -100.0% |
| Q2 2018 | $267,000 | -10.7% | 3,342 | -3.3% | 0.00% | 0.0% |
| Q1 2018 | $299,000 | +37.2% | 3,455 | +9.1% | 0.00% | – |
| Q4 2017 | $218,000 | -19.3% | 3,167 | +5.9% | 0.00% | -100.0% |
| Q3 2017 | $270,000 | +6.7% | 2,990 | -12.3% | 0.00% | 0.0% |
| Q2 2017 | $253,000 | +148.0% | 3,409 | +211.3% | 0.00% | – |
| Q1 2017 | $102,000 | +22.9% | 1,095 | -3.7% | 0.00% | – |
| Q4 2016 | $83,000 | – | 1,137 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tiger Eye Capital LLC | 239,122 | $41,392,000 | 8.25% |
| Integral Health Asset Management, LLC | 88,000 | $15,233,000 | 4.53% |
| Iron Triangle Partners LP | 168,761 | $29,213,000 | 3.79% |
| Eos Focused Equity Management, L.P. | 14,002 | $2,424,000 | 2.37% |
| PFM Health Sciences, LP | 311,940 | $53,997,000 | 1.90% |
| Perceptive Advisors | 977,565 | $169,217,000 | 1.82% |
| Rock Springs Capital Management LP | 395,000 | $68,375,000 | 1.45% |
| Lisanti Capital Growth, LLC | 54,302 | $9,400,000 | 1.30% |
| HealthCor Management, L.P. | 156,046 | $27,012,000 | 1.04% |
| FRED ALGER MANAGEMENT, LLC | 2,136,612 | $369,848,000 | 0.96% |